Search alternatives:
ms decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
wt decrease » we decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
p decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
19 p » 19 _ (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
ms decrease » a decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
wt decrease » we decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
_ decrease » _ decreased (Expand Search)
p decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
19 p » 19 _ (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
1
-
2
-
3
-
4
-
5
Significant decrease of SMAD4 protein in DBA iPSCs.
Published 2015“…<p>DBA iPSCs (labelled as “<i>RPS19/RPL5</i> mutant” or “<i>RPS19/RPL5</i> mutant-”), the corrected DBA cells (expressing a WT version of the mutated gene, <i>RPL5</i> or <i>RPS19</i>, labelled as “<i>RPS19/RPL5</i> mutant <i>RPS19/RPL5</i>” or “corrected <i>RPS19/RPL5</i> mutant”) and the control GFP cells (expressing GFP, labelled as “<i>RPS19/RPL5</i> mutant GFP”) were cultured and the nuclear and cytoplasmic protein was extracted from iPSCs for western blot analysis, and RNA for q-PCR analysis. …”
-
6
-
7
Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs.
Published 2015“…E) Western blot showing the decrease of p-SMAD3 in the nuclear fraction in both DBA iPS lines, and the nuclear p-SMAD3 protein partially restored in the corrected DBA iPSCs in the <i>RPS19</i> corrected line, but not in <i>RPL5</i> corrected line.…”
-
8
-
9
-
10
Proteasome activity was decreased in the <i>myc-rpt6-S119A</i> mutant.
Published 2017“…<p>(A) Lysates from strains in stationary phase (A<sub>600</sub>>5.0) were subjected to native gel electrophoresis followed by an in-gel activity assay with the fluorogenic proteasome substrate Suc-LLVY-AMC. …”
-
11
-
12
-
13
-
14
-
15
-
16
-
17
SLE decreases risk for hormonal cancers.
Published 2021“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
-
18
-
19
-
20